Dr Fangli Chen > Proskauer Rose LLP > Boston, United States > Lawyer Profile
Proskauer Rose LLP Offices
ONE INTERNATIONAL PLACE, 14TH FLOOR
BOSTON, MA 02110-2600
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Dr Fangli Chen
Work Department
Litigation
Position
Dr. Fangli Chen is a partner in the Litigation Department and vice-chair of the Life Sciences Patent Practice. She represents all types of companies in the biotech and pharmaceutical industries, and has deep scientific expertise and a strong business sense. Fangli effectively identifies and transforms technological developments into valuable intellectual property assets for her clients and specializes in the strategic development of complex IP portfolios for companies that align with their business goals.
Fangli’s practice also focuses on post-grant review before the USPTO, oppositions, pre-litigation and litigation strategy, due diligence investigations, freedom-to-operate, non-infringement and invalidity analysis, licensing and other IP matters in connection with commercial transactions. She handles a variety of technology areas including biochemistry, molecular and cell biology, immunotherapy, enzyme replacement therapy, nucleic acid based technologies including messenger RNA therapy, gene therapy, gene editing, antisense and oligonucleotides based therapies, vaccines, bioinformatics, and small molecule compound drugs.
Fangli also has a wealth of experience in the following areas:
Post-grant challenges: representing clients in inter partes review interference and various foreign opposition proceedings.
Technology transactions & licensing: advising clients on matters relating to technology or material transfer, licensing and research collaborations.
Investment or acquisition counsel: assisting investors in assessing the technology and intellectual property assets and risks for potential target investments and counseling companies on intellectual property matters in connection with public offering or acquisition.
Lawyer Rankings
United States > Healthcare > Life sciences
Proskauer Rose LLP provides a diverse offering for clients seeking advice on FDA regulation and patent prosecution. Boston-based practice head Fangli Chen assists clients with patent portfolio management to protect biochemical, immunology, and diagnostics products. New York’s Daryn Grossman acts as the managing partner of the firm, while practice co-head Siegmund Gutman – based in Los Angeles – is an accomplished litigator who acts for biotech, biologics, and medical device clients in disputes concerning biosimilars and Hatch-Waxman legislation. New York based Robert Cantone maintains a corporate-focused practice, advising on life sciences M&A, strategic alliances, and corporate governance.
Lawyer Rankings
Top Tier Firm Rankings
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- M&A/corporate and commercial > Venture capital and emerging companies
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Intellectual property > Copyright
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Industry focus > Sport
- Labor and employment > Workplace and employment counseling
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Insurance > Advice to policyholders
- Investment fund formation and management > Alternative/hedge funds
- Intellectual property > Copyright
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Labor and employment > ERISA litigation
- Dispute resolution > General commercial disputes
- Tax > International tax
- Tax > Not-for-profit (nonprofit and tax exempt organizations)
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Real estate > Real estate investment trusts (REITs)
- Tax > US taxes: non-contentious
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Immigration
- Media, technology and telecoms > Media and entertainment: litigation
- Finance > Restructuring (including bankruptcy): corporate
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Environment > Environment: transactional
- Healthcare > Life sciences
- Media, technology and telecoms > Media and entertainment: transactional
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Securities litigation: defense
- Healthcare > Service providers
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Intellectual property > Trademarks: litigation
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending